Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Pegcetacoplan, a C3 inhibitor (2021 FDA approved) from the compstatin family, served as a pivotal validation of C3-targeted treatment.
Lamers et al. 2022 Trends in Pharmacological Sciences, 43(8): 629…